
Corepressor

In the field of molecular biology, a corepressor is a molecule that represses the expression of genes.""l In prokaryotes, corepressors are small molecules whereas in
eukaryotes, corepressors are proteins. A corepressor does not directly bind to DNA, but instead indirectly regulates gene expression by binding to repressors.

A corepressor downregulates (or represses) the expression of genes by binding to and activating a repressor transcription factor. The repressor in turn binds to a
gene's operator sequence (segment of DNA to which a transcription factor binds to regulate gene expression), thereby blocking transcription of that gene.

Contents [hide]
a ae
Examples of corepressors

NCoR

NCOoR (nuclear receptor co-repressor) directly binds to the D and E domains of nuclear receptors and represses their transcriptional activity.) Class | histone
deacetylases are recruited by NCoR through SIN3, and NCOR directly binds to class II histone deacetylases.®101]

Silencing mediator for retinoid and thyroid-hormone receptor

SMRT (silencing mediator of retinoic acid and thyroid hormone receptor), also known as NCOR2, is an alternatively spliced SRC-1 (steroid receptor coactivator-1) (891 it
is negatively and positively affected by MAPKKK (mitogen activated protein kinase kinase kinase) and casein kinase 2 phosphorylation, respectively." SMRT has two
major mechanisms: first, similar to NCOR, SMRT also recruits class | histone deacetylases through SIN3 and directly binds to class II histone deacetylases."! Second, it
binds and sequesters components of the general transcriptional machinery, such as transcription factor II B.[81"91
Role in biological processes
Corepressors are known to regulate transcription through different activation and inactivation states.!"7II"1

NCoR and SMRT act as a corepressor complex to regulate transcription by becoming activated once the ligand is bound.!"2I("3I("4II15] Knockouts of NCOR resulted in
embryo death, indicating its importance in erythrocytic, thymic, and neural system development.!"51I"61

Mutations in certain corepressors can result in deregulation of signals.\"3) SMRT contributes to cardiac muscle development, with knockouts of the complex resulting in
less developed muscle and improper development.!"3)

NCOoR has also been found to be an important checkpoint in processes such as inflammation and macrophage activation_{'5)

Recent evidence also suggests the role of corepressor RIP140 in metabolic regulation of energy homeostasis.!'4)
Clinical significance

Diseases
Since corepressors participate and regulate a vast range of gene expression, it is not surprising that aberrant corepressor activities can cause diseases.!"7]

Acute myeloid leukemia (AML) is a highly lethal blood cancer characterized by uncontrolled myeloid cell growth.!"8! Two homologous corepressor genes, BCOR (BCL6
corepressor) and BCORL1, are recurrently mutated in AML patients.!'920 BCOR works with multiple transcription factors and is known to play vital regulatory roles in
embryonic development.!"8I!'91 Clinical results detected BCOR somatic mutations in ~4% of an unselected group of AML patients, and ~17% in a subset of patients who
lack known AML-causing mutations. "8191 similarly, BCORL1 is a corepressor that regulates cellular processes,'21! and was found to be mutated in ~6% of tested AML
patients.!'820l These studies point out a strong association between corepressor mutations and AML. Further corepressor research may reveal potential therapeutic
targets for AML and other diseases

Therapeutic Potential
Corepressors present many potential avenues for drugs to target a vast range of diseases.|?1

BCL6 upregulation is observed in cancers such as diffuse large B-cell lymphomas (DLBCLs),224125128] colorectal cancer,27128) and lung cancer.291201 BCL-6
corepressor, SMRT, NCR, and other corepressors are able to interact with and transcriptionally repress BCL6.(231(241(251261 small-molecule compounds, such as
synthetic peptides that target BCL6 and corepressor interactions,!254) as well as other protein-protein interaction inhibitors,(6) have been shown to effectively kill
cancer cells.

Activated liver X receptor (LXR) forms a complex with corepressors to suppress the inflammatory response in rheumatoid arthritis, making LXR agonists like GW3965 a
potential therapeutic strategy.(°11l21 Ursodeoxycholic acid (UDCA), by upregulating the corepressor small heterodimer partner interacting leucine zipper protein (SMILE),
inhibits the expression of IL-17, an inflammatory cytokine, and suppresses Th17 cells, both implicated in rheumatoid arthritis.291%41 This effect is dose-dependent in
humans, and UCDA is thought to be another prospective agent of rheumatoid arthritis therapy.!331
References [edit]

1.4 Privalsky, Martin L., ed. (2001). Transcriptional Corepressors: Mediators of
Eukaryotic Gene Repression &. Current Topics in Microbiology and Immunology.
Vol. 254. Berlin, Heidelberg: Springer Berlin Heidelberg.
doi:10.1007/978-3-662-10595-5 cz. ISBN 978-3-642-08709-7. S2CID 8922796 :2

2. Evans PD, Jaseja M, Jeeves M, Hyde El (December 1996). "NMR studies of
the Escherichia coli Trp repressor.trpRs operator complex" 2. Eur. J. Biochem. 242
(3): 567-75. doi:10.1111/}.1432-1033.1996.0567r-x @. PMID 9022683.

3. 4 Foster JB, Slonczewski J (2010). Microbiology: An Evolving Science
(Second ed.). New York: W. W. Norton & Company. ISBN 978-0-393-93447-2

4. 4 Jenster G (August 1998). "Coactivators and corepressors as mediators of nuclear
receptor function: an update”. Mol. Cell. Endocrinol. 143 (1-2): 1-7.
doi:10.1016/S0303-7207(98)00145-2 2. PMID 9806345 :2. S2CID 26244186.

5. * Lazar MA (2003). "Nuclear receptor corepressors” . Nucl Recept Signal. 1
001. doi:10.1621/nrs.01001 @. PMC 1402229. PMID 166041742

6. * Goodson M, Jonas BA, Privalsky MA (2005). "Corepressors: custom tailoring
and alterations while you wait" 4. Nucl Recept Signal. 3 (Oct 21): £003
doi:10.1621/nrs.03003 2. PMC 1402215. PMID 166041712

7.4 Schaefer U, Schmeier S, Bajic VB (January 2011). "TcoF-DB: dragon database
for human transcription co-factors and transcription factor interacting proteins” cz
Nucleic Acids Res. 39 (Database issue): D106—10. doi:10.1093/nar/gkq945 2
PMC 3013796 3. PMID 20965969 2

8.42 ed ef Bolander, Franklyn F. (2004), "Hormonally Regulated Transcription
Factors” zt, Molecular Endocrinology, Elsevier, pp. 387-443,
doi:10.1016/b978-012111232-5/50013-0 x2, ISBN 978-0-12-111232.5, retrieved
2020-10-25

9. "2 Chinnadurai, G (February 2002). "CtBP. an Unconventional Transcriptional
Corepressor in Development and Oncogenesis” 7. Molecular Cell. 9 (2): 213-224.
doi:10.1016/S1097-2765(02}00443-4. PMID 11864595 v2

10. "2" © Kammer, Gary M. (2004), "Estrogen, Signal Transduction, and Systemic
Lupus Erythematosus: Molecular Mechanisms" , Principles of Gender-Specific
Medicine, Elsevier, pp. 1082-1092, doi:10.1016/b978-012440905-7/50375-3 2,
ISBN 978-0-12-440905-7, retrieved 2020-10-25

11. * Kadamb, Rama; Mittal, Shilpi: Bansal, Nidhi; Batra, Harish: Saluja, Daman
(August 2013). "Sin3: Insight into its transcription regulatory functions”. European
Journal of Cell Biology. 92 (8-9): 237-246. doi:10.1016/j.ejcb.2013.09.001 2
PMID 2418916922

12. "2 Rosenfeld, M. G. (2006-06-01). "Sensors and signals: a
coactivator/corepressor/epigenetic code for integrating signal-dependent
programs of transcriptional response”. Genes & Development. 20 (11):
1405-1428. doi:10.1101/gad.1424806 3. ISSN 0890-9369 cz. PMID 1675117912

13. "2" 64 Battaglia, Sebastiano; Maguire, Orla; Campbell, Moray J. (2010).
“Transcription factor co-repressors in cancer biology: roles and targeting" ct
Intemational Journal of Cancer. 126 (11): 2511-9. doi:10.1002/ijc.25181 2
PMC 2847647 3. PMID 20091860

14. "2 ® Christian, Mark; White, Roger; Parker, Malcolm G. (August 2006)
"Metabolic regulation by the nuclear receptor corepressor RIP140" c2. Trends in
Endocrinology & Metabolism. 17 (6): 243-250. doi:10.1016/j.ter.2006.06.008 2
PMID 16815031. S2CID 45870845

15. "#2 ¢ Ogawa, S.: Lozach, J.; Jepsen, K.; Sawka-Verhelle, D.; Perissi, V.; Sasik,
R.; Rose, D. W.: Johnson, R. S.: Rosenfeld, M. G.; Glass, C. K. (2004-10-05). "A
nuclear receptor corepressor transcriptional checkpoint controlling activator
protein 1-dependent gene networks required for macrophage activation”
Proceedings of the National Academy of Sciences. 101 (40): 14461-14466
Bibcode:2004PNAS..101144610 12. doi:10.1073/pnas.0405786101 3
ISSN 0027-8424 e2. PMC 521940. PMID 15452344c2

16. * Jepsen, Kristen; Hermanson, Ola: Onami, Thandi M; Gleiberman, Anatoli S:
Lunyak, Victoria; McEvilly, Robert J: Kurokawa, Riki; Kumar, Vivek: Liu, Forrest;
Seto, Edward; Hedrick, Stephen M (September 2000). "Combinatorial Roles of
the Nuclear Receptor Corepressor in Transcription and Development" :2. Cell. 102
(6): 753-763. doi:10.1016/S0092-8674(00)00064-7 @. PMID 11030619 «2
S2CID 15645977 2

17. * Privalsky, Martin L. (March 2004). "The Role of Corepressors in Transcriptional
Regulation by Nuclear Hormone Receptors” c2. Annual Review of Physiology. 66 (1):
315-360. doi:10.1146/annurev physiol. 65.032802. 155556 c7. ISSN 0066-4278 2
PMID 14977406 <2

18.822 e4Tiacci, E.; Grossmann, V.; Martelli, M. P.; Kohlmann, A.: Haferlach, T.;
Falini, B. (2011-12-30). "The corepressors BCOR and BCORL1: two novel players
in acute myeloid leukemia" cz. Haematologica. 97 (1): 3-5.
doi:10.3324/haematol.2011.057901 @. ISSN 0390-6078 c2. PMC 32489233,

PMID 222103272

19. "22 © Grossmann, Vera: Tiacci, Enrico: Holmes, Antony B.; Kohlmann, Alexander;
Martelli, Maria Paola; Kern, Wolfgang: SpanholRosseto, Ariele: Klein, Hans-Ulrich;
Dugas, Martin; Schindela, Sonja; Trifonov, Vladimir (2011-12-01). "Whole-exome
sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with
normal karyotype". Blood. 118 (23): 6153-6163. doi:10.1182/blood-
2011-07-365320 2. ISSN 0006-4971 «7. PMID 220120662.
20

2

22.

23.

24.

25.

26

2.

28.

29

30.

El

32

33

34.

2 Li, Meng: Collins, Roxane: Jiao, Yuchen: Quillette, Peter: Bixby, Dale: Erba,
Harry: Vogelstein, Bert; Kinzler, Kenneth W.: Papadopoulos, Nickolas; Malek,
Sami N. (2011-11-24). "Somatic mutations in the transcriptional corepressor gene
BCORLI in adult acute myelogenous leukemia" cz. Blood. 118 (22): 5914-5917.
doi:10.1182/blood-2011-05-356204@. ISSN 0006-4971 7. PMC 3228503 3.
PMID 21989985 e2
* Pagan, Julia K.; Amold, Jeremy; Hanchard, Kim J.; Kumar, Raman: Bruno,
Tiziana; Jones, Mathew J. K.; Richard, Derek J.; Forrest, Alistair; Spurdle,
‘Amanda; Verdin, Eric; Crossley, Merlin (2007-03-22). "A Novel Corepressor,
BCoR-L1, Represses Transcription through an Interaction with CtBP" cz. Journal of
Biological Chemistry. 282 (20): 15248-15257. doi:10.1074/jbc.m700246200 3,
ISSN 0021-9258 e2. PMID 17379597
* Vaiopoulos, Aristeidis G.: Kostakis, loannis D.: Athanasoula, Kalliopi Ch.;
Papavassiliou, Athanasios G. (June 2012). "Targeting transcription factor
corepressor in tumor cells” 7. Cellular and Molecular Life Sciences. 69 (11)
1745-1753. doi:10.1007/s00018-012-0986-5 :2. ISSN 1420-682X
PMID 225277192. S2CID 16407925
“@® © Cerchietti, Leandro C.; Ghetu, Alexandru F.; Zhu, Xiao; Da Silva, Gustavo F.;
Zhong, Shijun; Matthews, Marilyn; Bunting, Karen L.: Polo, Jose M.; Farés,
Christophe; Arrowsmith, Cheryl H.; Yang, Shao Ning (April 2010). "A Small-
Molecule Inhibitor of BCLS Kills DLBCL Cells In Vitro and In Vivo" 2. Cancer Cell
7 (4): 400-411. doi10.1016)}.ccr.2009.12.050 a. PMC 28583953.
PMID 203853642
"8 © Cerchietti, Leandro C.; Yang, Shao Ning: Shaknovich, Rita; Hatzi, Katerina:
Polo, Jose M.: Chadbum, Amy; Dowdy, Steven F.; Melnick, Ari (2009-04-09). "A
peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in
vivo" @. Blood. 113 (15): 3397-3405. doi:10.1182/blood-2008-07-168773 2.
ISSN 0006-4971 cz. PMC 2668844. PMID 18927431
“2 Parekh, Samir; Privé, Gilbert; Melnick, Ari (January 2008). "Therapeutic
targeting of the BCL6 oncogene for diftuse large B-cell lymphomas” c2. Leukemia &
Lymphoma. 49 (5): 874-882. doi:10.1080/10428190801895345
ISSN 1042-8194 2. PMC 2748726. PMID 18452090 2
"8 © Yasui, Takeshi; Yamamoto, Takeshi: Sakai, Nozomu: Asano, Kouhei: Takai,
Takafumi: Yoshitomi, Yayoi; Davis, Melinda: Takagi, Terufumni; Sakamoto, Kotaro:
Sogabe, Satoshi; Kamada, Yusuke (September 2017). "Discovery of a novel
B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-
based drug design” 2. Bioorganic & Medicinal Chemistry. 25 (17): 4876-4886
doi:10.1016/j.bmc.2017.07.037 cz. PMID 28760529.
* Sena, Paola; Mariani, Francesco; Benincasa, Marta: De Leon, Maurizio Ponz: Di
Gregorio, Carmela: Mancini, Stefano: Cavani, Francesco: Smargiassi, Alberto:
Palumbo, Carla; Roncucci, Luca (January 2014). "Morphological and quantitative
analysis of BCL6 expression in human colorectal carcinogenesis” 7. Oncology
Reports. 31 (1): 103-110. doi:10.3892/or 2013. 2846. ISSN 1021-335X2
PMID 24220798 «2
* Sun, Naihui; Zhang, Liang: Zhang, Chongguang: Yuan, Yuan (December 2020)
“miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6
via inhibition of Wnt/f-catenin signaling’ :2. Cellular & Molecular Biology Letters. 25
(1): 19. doi:10.1186/s11658-020-00210-3 -2. ISSN 1425-81532. PMC 70794153.
PMID 32206063 e2
* Deb, Dhruba: Rajaram, Satwik; Larsen, Jill E.; Dospoy, Patrick D.: Marullo,
Rossella: Li, Long Shan: Avila, Kimberley: Xue, Fengtian: Cerchietti, Leandro:
Minna, John D.; Altschuler, Steven J. (2017-06-01). "Combination Therapy
Targeting BCL6 and Phospho-STAT3 Defeats Intratumor Heterogeneity in a
Subset of Non-Small Cell Lung Cancers” . Cancer Research. 77 (11): 3070-3081
doi:10.1158/0008-5472. CAN-15-3052 2. ISSN 0008-5472 2. PMC 5489259 3.
PMID 2837745322
* Sun, Chengcao: Li, Shujun: Yang, Cuil: Xi, Yongyong: Wang, Liang: Zhang,
Feng: Li, Dejia (February 2016). "MicroRNA-187-3p mitigates non-small cell lung
cancer (NSCLC) development through down-regulation of BCL6" 7. Biochemical and
Biophysical Research Communications. 471 (1): 82-88
doi:10.1016/,.bbrc.2016.01.175 cz. PMID 26845350
* Venteclef, N.; Jakobsson, T.: Ehrlund, A; Damdimopoulos, A.: Mikkonen, L.:
Ellis, E.: Nilsson, L-M.; Parini, P; Janne, O. A: Gustafsson, J-A.; Steffensen, K.
R. (2010-02-15). "GPS2-dependent corepressor/SUMO pathways govern anti-
inflammatory actions of LRH-1 and LXR in the hepatic acute phase response” 2
Genes & Development. 24 (4): 381-395. doi:10.1101/gad.545110 ez
ISSN 0890-9369 «2. PMC 2816737. PMID 20159957
* Yoon, Chong-Hyeon; Kwon, YonguJin; Lee, Sang-Won: Park, Yong-Beom: Lee,
Soo-Kon; Park, Min-Chan (January 2013). "Activation of Liver X Receptors,
Suppresses Inflammatory Gene Expressions and Transcriptional Corepressor
Clearance in Rheumatoid Arthritis Fibroblast Like Synoviocytes" c?. Journal of
Clinical Immunology. 33 (1): 190-199. doi:10.1007/s10875-012-9799-4 «2
ISSN 0271-9142 2. PMID 22990668 2. S2CID 15965750
“2 Lee, Eun-Jung: Kwon, Jeong-Eun; Park, Min-Jung; Jung, Kyung-Ah; Kim, Da-
Som: Kim, Eun-Kyung: Lee, Seung Hoon: Choi, Jong Young: Park, Sung-Hwan:
Cho, Mi-La (August 2017). "Ursodeoxycholic acid attenuates experimental
autoimmune arthritis by targeting Th17 and inducing pAMPK and transcriptional
corepressor SMILE" @. Immunology Letters. 188: 1-8.
doi:10.1016/,.imlet.2017.05.011 7. PMID 28539269
* Sarkar, Sujata; Fox, David A. (May 2010). "Targeting IL-17 and Th17 Cells in
Rheumatoid Arthritis” . Rheumatic Disease Clinics of North America. 36 (2):
345-366. doi:10.1016/jrdc.2010.02.006.7. PMID 20510238.